Ferro, M., Ungaro, P., Cimmino, A., Lucarelli, G., Busetto, G. M., Cantiello, F., . . . Terracciano, D. (2017). Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS). Int J Mol Sci.
Citação norma ChicagoFerro, Matteo, Paola Ungaro, Amelia Cimmino, Giuseppe Lucarelli, Gian Maria Busetto, Francesco Cantiello, Rocco Damiano, and Daniela Terracciano. "Epigenetic Signature: A New Player As Predictor of Clinically Significant Prostate Cancer (PCa) in Patients On Active Surveillance (AS)." Int J Mol Sci 2017.
Citação norma MLAFerro, Matteo, et al. "Epigenetic Signature: A New Player As Predictor of Clinically Significant Prostate Cancer (PCa) in Patients On Active Surveillance (AS)." Int J Mol Sci 2017.